Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis
Publication date: November 2026 Source: Journal of Thrombosis and Haemostasis, Volume 24, Issue 11 Author(s): Milan Vujčić, Sanja Madunić, Jasminka Jakelić Piteša, Marija Petrić, Davor Galušić, Ena Ranković, Ana Boban
Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S1538783626005313?dgcid=rss_sd_all
Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S1538783626005313?dgcid=rss_sd_all
“Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis.” Journal of Thrombosis and Haemostasis.
@article{article56256,
title = {Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S1538783626005313?dgcid=rss_sd_all}
}